Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Merkel

Showing results (191-200 of 434) with videos related to

Pageof 44
Sort By:
Sleep Medicine|July 1, 2026
Sleep disturbances in patients with vasculitisMisa Tanaka, Saverio Stranges, Kathy Speechley, et al.
The Patient|April 27, 2021
Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future DirectionsW Benjamin Nowell, Peter A Merkel, Robert N McBurney, et al.
Annals of the Rheumatic Diseases|April 19, 2018
Comparison of magnetic resonance angiography and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitisKaitlin A Quinn, Mark A Ahlman, Ashkan A Malayeri, et al.
The Journal of Rheumatology|September 17, 2015
Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014Gulen Hatemi, Yesim Ozguler, Haner Direskeneli, et al.
Journal of Autoimmunity|November 9, 2025
Genetic susceptibility and validation of angiographic patterns in Takayasu arteritisDesiré Casares-Marfil, K Bates Gribbons, Guher Saruhan-Direskeneli, et al.
Seminars in Arthritis and Rheumatism|May 6, 2022
An international Delphi exercise to identify items of importance for measuring response to treatment in ANCA-associated vasculitisKaitlin A Quinn, Sara Monti, Robin Christensen, et al.
The Journal of Rheumatology|January 17, 2014
Current status of outcome measure development in vasculitisPeter A Merkel, Sibel Z Aydin, Maarten Boers, et al.
Annals of the Rheumatic Diseases|November 12, 2025
Effects of clofutriben, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, on the efficacy and toxicity of prednisolone in patients with polymyalgia rheumatica: a single-blind controlled trial with sequential cohortsFrank Buttgereit, Andrea Everding, Ioana Andreica, et al.
Arthritis Care & Research|December 1, 2019
Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient-, Physician-, Imaging-, and Laboratory-Based AssessmentsCasey A Rimland, Kaitlin A Quinn, Joel S Rosenblum, et al.
The Journal of Rheumatology|July 5, 2011
Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agendaHaner Direskeneli, Sibel Z Aydin, Tanaz A Kermani, et al.
Pageof 44

Showing results (191-200 of 434) with videos related to

Sort By:
Pageof 44
Sleep Medicine|July 1, 2026
Sleep disturbances in patients with vasculitisMisa Tanaka, Saverio Stranges, Kathy Speechley, et al.
The Patient|April 27, 2021
Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future DirectionsW Benjamin Nowell, Peter A Merkel, Robert N McBurney, et al.
Annals of the Rheumatic Diseases|April 19, 2018
Comparison of magnetic resonance angiography and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitisKaitlin A Quinn, Mark A Ahlman, Ashkan A Malayeri, et al.
The Journal of Rheumatology|September 17, 2015
Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014Gulen Hatemi, Yesim Ozguler, Haner Direskeneli, et al.
Journal of Autoimmunity|November 9, 2025
Genetic susceptibility and validation of angiographic patterns in Takayasu arteritisDesiré Casares-Marfil, K Bates Gribbons, Guher Saruhan-Direskeneli, et al.
Seminars in Arthritis and Rheumatism|May 6, 2022
An international Delphi exercise to identify items of importance for measuring response to treatment in ANCA-associated vasculitisKaitlin A Quinn, Sara Monti, Robin Christensen, et al.
The Journal of Rheumatology|January 17, 2014
Current status of outcome measure development in vasculitisPeter A Merkel, Sibel Z Aydin, Maarten Boers, et al.
Annals of the Rheumatic Diseases|November 12, 2025
Effects of clofutriben, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, on the efficacy and toxicity of prednisolone in patients with polymyalgia rheumatica: a single-blind controlled trial with sequential cohortsFrank Buttgereit, Andrea Everding, Ioana Andreica, et al.
Arthritis Care & Research|December 1, 2019
Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient-, Physician-, Imaging-, and Laboratory-Based AssessmentsCasey A Rimland, Kaitlin A Quinn, Joel S Rosenblum, et al.
The Journal of Rheumatology|July 5, 2011
Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agendaHaner Direskeneli, Sibel Z Aydin, Tanaz A Kermani, et al.
Pageof 44